GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Panion & BF Biotech 1760.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

49.30

+0.72%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Panion & BF Biotech

Its shares trade on Taiwan Stock Exchange under the ticker 1760.TW. It has been listed since 14 June 2004. In the fiscal year to 31 December 2025, it reported revenue of TWD 2.06bn and net income of TWD 190.2m. At that date it held total assets of TWD 3.23bn and shareholders' equity of TWD 1.95bn.

Panion & BF Biotech, Inc. engages in the manufacturing and sales of medicines, cosmetics, and formula foods. The company is headquartered in Taipei City, Taipei. The company went IPO on 2004-06-14. The firm is also involved in the manufacture and sales of various kinds of cosmetics. The firm's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The firm also provides biotechnology services. The firm distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
14 Jun 2004
Website
pbf.com.tw ↗

Leadership

Pay as last reported

  • Mr. Li-Chiou ChangChairman of the Board, since 2016
  • Mr. Chung-Ming ChiangGeneral Manager, Director, since 1980
  • Mr. Chung-Chi TsaiDeputy General Manager-Operation Management, Corporate Governance Officer, since 2024
  • Mr. Te-En ChenDeputy General Manager-Subsidiary
  • Mr. Yu-Sheng HsuehDeputy General Manager
  • Mr. Chun-Ping LuDeputy General Manager
  • Mr. Feng-Jen WangDeputy General Manager
  • Ms. Mei-Lun ChiuHead of Accounting
  • Mr. Pa-Chuan ChenDirector
  • Mr. De-Fu HsiehDirector
  • Mr. Weng-Houng HuangDirector
  • Mr. Jyh-Ming LinDirector, since 1998

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Panion & BF Biotech Inc has several key strengths that contribute to its success in the market. These strengths include:

Weaknesses

  • Despite its strengths, Panion & BF Biotech Inc also faces certain weaknesses that need to be addressed to maintain competitiveness:

Opportunities

  • Panion & BF Biotech Inc can leverage the following opportunities to further expand its business and market share:

Threats

  • Panion & BF Biotech Inc must be aware of the potential threats that could negatively impact its growth and profitability:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.